Pacific Biosciences of California Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Pacific Biosciences of California Inc.
- Former names
- Nanofluidics Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 3826 — Laboratory Analytical Instruments
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Menlo Park
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PACB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001299130
- EIN
- 16-1590339
Board of directors
-
Christopher Gibson · DirectorSince 2026
-
Christopher M. Smith · DirectorSince 2025
-
David Botstein · DirectorSince 2023
-
David W. Meline · DirectorSince 2023
-
Hannah Valantine · DirectorSince 2023
-
John F. Milligan · DirectorSince 2023
-
Kathy Ordonez · DirectorSince 2023
-
Lucy Shapiro · DirectorSince 2023
-
Marshall Mohr · DirectorSince 2023
-
Randall S. Livingston · DirectorSince 2023
-
William W. Ericson · DirectorSince 2023
Director election results
Annual meeting of June 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.0%
-
95.8%
-
95.9%
-
97.0%
-
97.0%
Board connections
6 of this board's directors also sit on 9 other boards.
- via John F. Milligan
- via Hannah Valantine
- via Hannah Valantine
- via David W. Meline
- via David W. Meline
- via John F. Milligan
- via Christopher M. Smith
- via Christopher Gibson
- via Marshall Mohr
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,313,174
- 11 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Van Oene Mark Officer (See Remarks) | Open-market sale | −26,911 | $1.13 | $30,409 |
| Aug 10, 2026 | Van Oene Mark Officer (See Remarks) | Grant or award | +489,130 | — | — |
| Apr 8, 2026 | Christopher Gibson Director | Grant or award | +57,473 | — | — |
| Apr 1, 2026 | Gibson James R II Officer (See Remarks) | Open-market sale | −88,185 | $1.37 | $120,813 |
| Mar 3, 2026 | Christopher Gibson Director | Grant or award | +53,913 | — | — |
| Mar 3, 2026 | Christian O. Henry Officer (See Remarks) | Open-market sale | −12,497 | $1.51 | $18,870 |
| Mar 3, 2026 | Van Oene Mark Officer (See Remarks) | Open-market sale | −6,504 | $1.51 | $9,821 |
| Mar 3, 2026 | Farmer Michele Officer (See Remarks) | Open-market sale | −2,979 | $1.51 | $4,498 |
| Feb 27, 2026 | Farmer Michele Officer (See Remarks) | Grant or award | +89,835 | — | — |
| Feb 27, 2026 | Gibson James R II Officer (See Remarks) | Grant or award | +333,848 | — | — |
| Feb 27, 2026 | Van Oene Mark Officer (See Remarks) | Grant or award | +500,000 | — | — |
| Feb 27, 2026 | Christian O. Henry Officer (See Remarks) | Grant or award | +920,810 | — | — |
| Feb 18, 2026 | Van Oene Mark Officer (See Remarks) | Open-market sale | −55,107 | $1.63 | $89,824 |
| Feb 18, 2026 | Christian O. Henry Officer (See Remarks) | Open-market sale | −140,874 | $1.63 | $229,625 |
| Feb 18, 2026 | Farmer Michele Officer (See Remarks) | Open-market sale | −14,952 | $1.63 | $24,372 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.